This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. slid 4.1% to $634.14 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.2% to 5,776.65 and the Dow Jones Industrial Average rising 0.0% to 42,587.50.
Regeneron Pharmaceuticals Inc. closed 47.6% below its 52-week high of $1,211.20, which the company reached on August 27th.
The stock underperformed when compared to some of its competitors, as Amgen Inc. fell 2.4% to $306.86, Moderna Inc. fell 0.9% to $33.85, and Gilead Sciences Inc. rose 1.08% to $107.89.
Trading volume totaled 848,623, compared to the 50-day average of 967,305.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 25, 2025 16:33 ET (20:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。